MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Research on the modifier gene of Hereditary spinocerebellar ataxia type 2

JLW. Wang, ZL. Liu (Changsha, China)

Meeting: 2019 International Congress

Abstract Number: 289

Keywords: Ataxia: Clinical features, Ataxia: Genetics, Spinocerebellar ataxias(SCA)

Session Information

Date: Monday, September 23, 2019

Session Title: Ataxia

Session Time: 1:45pm-3:15pm

Location: Les Muses, Level 3

Objective: To investigate the influence of CAG trinucleotides repeat of some (CAG)n-containing gene and some gene polymorphisms in AO of SCA2, and analyse the difference of these gene polymorphisms between PD-SCA2 group and A-SCA2 group.

Background: Hereditary spinocerebellar ataxia type 2(SCA2)is one of the most prevalent autosomal dominant ataxias in china, with a high degree of clinical heterogeneity. Previous researches showed that age at onset (AO) of SCA2 is negatively correlated with the CAG trinucleotides repeat lengths in ATXN2 gene. However, the correlation can not fully explain the variation of AO and clinical symptoms between different patients.

Method: We obtained the DNA samples and clinical data from 75 autosomal dominant familial SAC2 patients which had alrealy been diagnosed by gene test, and 11 sporadic SCA2 patients. We determined the size of CAG repeat length in two allele of ATXN2 gene and the long-chain allele of ATXN1, ATXN3, CACNA1A, ATXN7, TBP, ATN1, IT15, HDL2, KCNN3 gene using polymerase chain reaction (PCR) amplification and capillary electrophoresis.

Results: There were no other genes associated with AO, except for the correlation between AO and CAG repeat lengths in the ATXN2 gene (r = -0.515, P = 0.000).

Conclusion: In conclusion, the CAG repeat lengths in ATXN2 gene is the main genetic factor, which could explain 40.8% of AO variance.

To cite this abstract in AMA style:

JLW. Wang, ZL. Liu. Research on the modifier gene of Hereditary spinocerebellar ataxia type 2 [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/research-on-the-modifier-gene-of-hereditary-spinocerebellar-ataxia-type-2/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/research-on-the-modifier-gene-of-hereditary-spinocerebellar-ataxia-type-2/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley